Search Within

Craig Steven Sauter

Formats
  1. Meeting Abstract (204)
  2. Journal Article (113)
  3. Research Letter (8)
  4. Review (5)
  5. Guidelines (3)
  6. Book Section (2)
  7. Editorial (1)
Groups
  1. Bone Marrow Transplant (336)
  2. Center for Hematologic Malignancies (336)
  3. Department of Medicine (336)
  4. Hematologic Malignancies, Division of (336)
  5. Survivorship Research (234)
  6. CTCR Scholars (205)

More Groups

People
  1. Miguel-Angel Perales (195)
  2. Sergio Giralt (192)
  3. Parastoo Dahi (136)
  4. Sean Devlin (127)
  5. Esperanza Papadopoulos (101)
  6. Juliet Barker (94)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (14)
  4. 2022 (32)
  5. 2021 (36)
  6. 2020 (42)

More Years

Publications
  1. Blood (103)
  2. Biology of Blood and Marrow Transplantation (80)
  3. Bone Marrow Transplantation (26)
  4. Transplantation and Cellular Therapy (20)
  5. Blood Advances (18)
  6. Journal of Clinical Oncology (13)

More Publications

Publishers
  1. American Society of Hematology (121)
  2. Elsevier Inc. (106)
  3. Nature Publishing Group (35)
  4. American Society of Clinical Oncology (13)
  5. Wiley Blackwell (10)
  6. Taylor & Francis Group (9)

More Publishers

Results (336)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Schòˆder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Banked EBV-specific T-cells for treatment of rituximab refractory EBV plus B-cell lymphoma in solid organ transplantation recipients
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Sauter, C.; Suser, S.; O'Reilly, R.
    American Journal of Transplantation (2016)

    Fulltext@MSK | Save
  • A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation
    Journal Article

    Hobbs, G. S.; Kaur, N.; Hilden, P.; Ponce, D.; Cho, C.; Castro-Malaspina, H. R.; Giralt, S.; Goldberg, J. D.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of <= 12 months
    Journal Article

    Lunning, M. A.; Migliacci, J. C.; Hilden, P.; Devlin, S. M.; Castro-Malaspina, H.; Giralt, S.; Perales, M. A.; Zelenetz, A. D.; Moskowitz, C. H.; Sauter, C. S.
    British Journal of Haematology (2016)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T cells for cancer immunotherapy
    Meeting Abstract

    Curran, K. J.; Silverman, L. B.; Kobos, R.; Kernan, N. A.; Margossian, S. P.; Park, J. H.; Sauter, C. S.; Szenes, V.; Wang, X. Y.; O'Reilly, R. J.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • CD34+ selected ex-vivo T-cell depleted grafts for allogeneic hematopoietic cell transplantation is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
    Meeting Abstract

    Barba, P.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; Papadopoulos, E.; Sauter, C.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34+ selected grafts for allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Barba, P.; Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Impact of busulfan exposure on transplant outcomes for patients with advanced myelodysplastic syndrome undergoing CD34 selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Proli, A. J.; Tamari, R.; Zheng, J.; Jakubowski, A. A.; Papadopoulos, E.; Ponce, D. M.; Devlin, S. M.; Sauter, C. S.; Perales, M. A.; Young, J. W.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • CD34+ selected ex-vivo T-cell depleted (TCD) grafts for allogeneic hematopoietic cell transplantation (Allo-HSCT) is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
    Meeting Abstract

    Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Ciolino, C.; Dierov, D.; Herman, D.; Mosesso, K.; Nieves, J.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Outcomes of diffuse large B-cell lymphoma (DLBCL) patients progressing after autologous hematopoietic stem cell transplant
    Meeting Abstract

    Gil-Cupello, M.; Shah, G. L.; Maloy, M. A.; Goldman, D. A.; Devlin, S. M.; Matasar, M. J.; Giralt, S. A.; Sauter, C. S.; Moskowitz, C. H.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save